129 related articles for article (PubMed ID: 37805872)
1. A CLINICO-EPIDEMIOLOGICAL STUDY OF MULTIPLE SCLEROSIS IN MOSUL CITY, IRAQ.
Taher Y; Ahmed M; Majdal H
Georgian Med News; 2023; (340-341):47-52. PubMed ID: 37805872
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of multiple sclerosis in Iraq: retrospective review of 4355 cases and literature review.
Hassoun HK; Al-Mahadawi A; Sheaheed NM; Sami SM; Jamal A; Allebban Z
Neurol Res; 2022 Jan; 44(1):14-23. PubMed ID: 34409919
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and dynamics of disability progression in a cohort of patients with multiple sclerosis in Latvians.
Kalnina J; Trapina I; Sjakste N; Paramonova N
Neurol Sci; 2024 Jul; 45(7):3347-3358. PubMed ID: 38393441
[TBL] [Abstract][Full Text] [Related]
4. Multiple sclerosis in Jordan: A clinical and epidemiological study.
El-Salem K; Al-Shimmery E; Horany K; Al-Refai A; Al-Hayk K; Khader Y
J Neurol; 2006 Sep; 253(9):1210-6. PubMed ID: 16649096
[TBL] [Abstract][Full Text] [Related]
5. Approaches and challenges in the diagnosis and management of secondary progressive multiple sclerosis: A Central Eastern European perspective from healthcare professionals.
Boyko A; Therapontos C; Horakova D; Szilasiová J; Kalniņa J; Kolontareva J; Gross-Paju K; Selmaj K; Sereike I; Milo R; Gabelić T; Rot U
Mult Scler Relat Disord; 2021 May; 50():102778. PubMed ID: 33592384
[TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?
Al-Araji A; Mohammed AI
J Neurol Sci; 2005 Jul; 234(1-2):67-71. PubMed ID: 15946690
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological study of multiple sclerosis in La Rioja.
Bártulos Iglesias M; Marzo Sola ME; Estrella Ruiz LA; Bravo Anguiano Y
Neurologia; 2015; 30(9):552-60. PubMed ID: 24975346
[TBL] [Abstract][Full Text] [Related]
8. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.
Burt RK; Balabanov R; Han X; Sharrack B; Morgan A; Quigley K; Yaung K; Helenowski IB; Jovanovic B; Spahovic D; Arnautovic I; Lee DC; Benefield BC; Futterer S; Oliveira MC; Burman J
JAMA; 2015 Jan; 313(3):275-84. PubMed ID: 25602998
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt.
Zakaria M; Zamzam DA; Abdel Hafeez MA; Swelam MS; Khater SS; Fahmy MF; Abdel Hady A; Fouad MM; Abdel Nasser A; Aref H; Gadallah M
Mult Scler Relat Disord; 2016 Nov; 10():30-35. PubMed ID: 27919495
[TBL] [Abstract][Full Text] [Related]
10. Disability and prognosis of relapsing remitting multiple sclerosis, is it different in Iraqi patients?
Hasan ZN
Neurosciences (Riyadh); 2011 Jul; 16(3):233-6. PubMed ID: 21677613
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Multiple Sclerosis in Rio de Janeiro: Secondary Progression and Disability.
Cerqueira Pinto SC; Ferreira Vasconcelos CC; Aurenção JCK; Alvarenga MP; das Graças Gomes Camargo SM; Santos Thuler LC; Alvarenga RP
Pediatr Neurol; 2019 May; 94():48-54. PubMed ID: 30850228
[TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone: a review of its use in multiple sclerosis.
Scott LJ; Figgitt DP
CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
[TBL] [Abstract][Full Text] [Related]
13. The course of early-onset multiple sclerosis in Iraqi children.
Al-Hamadani HA; Abdalla AS; Al-Saffar AJ
World J Pediatr; 2012 Feb; 8(1):47-51. PubMed ID: 21633856
[TBL] [Abstract][Full Text] [Related]
14. Early onset multiple sclerosis and the effect of disease onset age on neurological disability in multiple sclerosis.
Usta NC; Boz C; Terzi M
Clin Neurol Neurosurg; 2023 Jan; 224():107528. PubMed ID: 36446265
[TBL] [Abstract][Full Text] [Related]
15. Glial and neuroaxonal biomarkers in a multiple sclerosis (MS) cohort.
Kalatha T; Hatzifilippou E; Arnaoutoglou M; Balogiannis S; Koutsouraki E
Hell J Nucl Med; 2019; 22 Suppl 2():113-121. PubMed ID: 31802051
[TBL] [Abstract][Full Text] [Related]
16. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of multiple sclerosis in Asahikawa, a city in northern Japan.
Itoh T; Aizawa H; Hashimoto K; Yoshida K; Kimura T; Katayama T; Koyama S; Yahara O; Kikuchi K
J Neurol Sci; 2003 Oct; 214(1-2):7-9. PubMed ID: 12972381
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of multiple sclerosis in Kuwait: data from the new MS registry of Amiri Hospital.
Alroughani R; Ashkanani A; Lamdhade S
Int J Neurosci; 2012 Feb; 122(2):82-7. PubMed ID: 21985585
[TBL] [Abstract][Full Text] [Related]
20. Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study.
D'Amico E; Patti F; Zanghì A; Chisari CG; Lo Fermo S; Zappia M
Eur J Neurol; 2018 Dec; 25(12):1425-1431. PubMed ID: 29956427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
